赛霉安保留灌肠治疗溃疡性结肠炎近期疗效观察  

Effect of Sai Mei-An enema on ulcerative colitis

作　　者：邹开芳[1] 刘诗[1] 易粹琼[1] 

机构地区：[1]同济医科大学附属协和医院消化内科,武汉430022

出　　处：《胃肠病学和肝病学杂志》2000年第2期131-132,共2页Chinese Journal of Gastroenterology and Hepatology

摘　　要：目的　观察赛霉安保留灌肠治疗轻、中度溃疡性结肠炎的疗效。方法　对 32例轻、中度末端溃疡性结肠炎病人随机分赛霉安治疗组 (2 0例 )和地塞米松治疗组 (12例 )保留灌肠治疗 1疗程后评估疗效。结果　症状缓解率和内镜缓解率赛霉安治疗组均为 90 % (18/2 0 ) ,地塞米松治疗组为 83 3 % (10 /12 )和 91 7% (11/12 ) ,两组差异无显著性意义(P >0 0 5 )。结论　赛霉安是一种纯中药制剂 ,局部治疗轻、中度溃疡性结肠炎有较好疗效 ,与地塞米松相似 ,且无明显副作用 。Aim To observe the effect of Sai Mei-An enema on slight or moderate ulcerative colitis.Method 32 patients with slight or moderate ulcerative colitis were randomly divided into Sai Mei-An group (20 cases) and Dexamethasone group (12 cases), the two drugs were given by enema. Results The remission rates of symptom and endoscope were all 90.0% in Sai Mei-An group, 83.3% and 91.7% respectively in Dexamethasone group. There were no statistical difference in the two group.Conclusions Comparing with Dexamethasone, Sai Mei-An is a traditional medical drug, has better efficiency in treating slight or moderate ulcerative colitis and no obvious side effects.

关 键 词：赛霉安 溃疡性结肠炎 灌肠 治疗 

分 类 号：R574.620.5[医药卫生—消化系统]